PWM
ABBV icon

Parkworth Wealth Management’s AbbVie ABBV Stock Holding History

Parkworth Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$17.6K Buy
95
+25
+36% +$4.65K 0.01% 131
2025
Q1 		$14.6K Sell
70
-61
-47% -$11.9K 0.01% 123
2024
Q4 		$23.2K Buy
+131
New +$24.1K 0.02% 113

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Parkworth Wealth Management's ABBV Position: Q2 2025 in Review

Parkworth Wealth Management increased its AbbVie (ABBV) stake by 36% in Q2 2025, buying an estimated $4.65K and bringing the position to 95 shares worth $17.6K. The position accounts for 0.01% of the portfolio, ranked #131.

Parkworth Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 3 quarters since. The position peaked at $23.2K in Q4 2024. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Parkworth Wealth Management held 95 shares of AbbVie worth $17.6K as of Q2 2025.
  • Parkworth Wealth Management bought 25 AbbVie shares in Q2 2025, an estimated $4.65K.
  • AbbVie made up 0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #131 holding.
  • Parkworth Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 3 quarters since.
  • Parkworth Wealth Management's AbbVie position peaked at $23.2K in Q4 2024.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.